Friday, May 12, 2017

Neuropsychopharmacology - Table of Contents alert Volume 42 Issue 7

If you are unable to see the message below, click here to view.


Volume 42, Issue 7 (June 2017)

In this issue
Review Article
Original Articles
In Memoriam

Also new
Follow NPP on Facebook Facebook

Follow NPP on Twitter Twitter

Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed



NPP: Our Designs for the Future

William A Carlezon, Jr and Anissa Abi-Dargham

Neuropsychopharmacology 2017 42: 1371-1372; 10.1038/npp.2017.54

Full Text



Will Viewing Overeating as Compulsive Lead to Novel Pharmacological Interventions?

Kristin N Javaras

Neuropsychopharmacology 2017 42: 1373-1374; advance online publication, January 6, 2017; 10.1038/npp.2017.29

Full Text

Review Article


Pathological Overeating: Emerging Evidence for a Compulsivity Construct

Catherine F Moore, Valentina Sabino, George F Koob and Pietro Cottone

Neuropsychopharmacology 2017 42: 1375-1389; advance online publication, December 6, 2016; 10.1038/npp.2016.269

Abstract | Full Text

Original Articles


Arbaclofen in Children and Adolescents with Autism Spectrum Disorder: A Randomized, Controlled, Phase 2 Trial

Jeremy Veenstra-VanderWeele, Edwin H Cook, Bryan H King, Peter Zarevics, Maryann Cherubini, Karen Walton-Bowen, Mark F Bear, Paul P Wang and Randall L Carpenter

Neuropsychopharmacology 2017 42: 1390-1398; advance online publication, October 17, 2016; 10.1038/npp.2016.237

Abstract | Full Text

Differential Abnormal Pattern of Anterior Cingulate Gyrus Activation in Unipolar and Bipolar Depression: an fMRI and Pattern Classification Approach

Christian Bürger, Ronny Redlich, Dominik Grotegerd, Susanne Meinert, Katharina Dohm, Ilona Schneider, Dario Zaremba, Katharina Förster, Judith Alferink, Jens Bölte, Walter Heindel, Harald Kugel, Volker Arolt and Udo Dannlowski

Neuropsychopharmacology 2017 42: 1399-1408; advance online publication, February 16, 2017; 10.1038/npp.2017.36

Abstract | Full Text

Effects of Oxytocin and Vasopressin on Preferential Brain Responses to Negative Social Feedback

Marta Gozzi, Erica M Dashow, Audrey Thurm, Susan E Swedo and Caroline F Zink

Neuropsychopharmacology 2017 42: 1409-1419; advance online publication, October 31, 2016; 10.1038/npp.2016.248

Abstract | Full Text

Intranasal Oxytocin and Vasopressin Modulate Divergent Brainwide Functional Substrates

Alberto Galbusera, Alessia De Felice, Stefano Girardi, Giacomo Bassetto, Marta Maschietto, Katsuhiko Nishimori, Bice Chini, Francesco Papaleo, Stefano Vassanelli and Alessandro Gozzi

Neuropsychopharmacology 2017 42: 1420-1434; advance online publication, December 20, 2016; 10.1038/npp.2016.283

Abstract | Full Text

Maternal Immune Activation Causes Behavioral Impairments and Altered Cerebellar Cytokine and Synaptic Protein Expression OPEN

Gurudutt Pendyala, Shinnyi Chou, Yoosun Jung, Pierluca Coiro, Elizabeth Spartz, Ragunathan Padmashri, Ming Li and Anna Dunaevsky

Neuropsychopharmacology 2017 42: 1435-1446; advance online publication, January 19, 2017; 10.1038/npp.2017.7

Abstract | Full Text

Improved Social Interaction, Recognition and Working Memory with Cannabidiol Treatment in a Prenatal Infection (poly I:C) Rat Model

Ashleigh L Osborne, Nadia Solowij, Ilijana Babic, Xu-Feng Huang and Katrina Weston-Green

Neuropsychopharmacology 2017 42: 1447-1457; advance online publication, February 23, 2017; 10.1038/npp.2017.40

Abstract | Full Text

The Trace Amine-Associated Receptor 1 Agonist RO5256390 Blocks Compulsive, Binge-like Eating in Rats

Antonio Ferragud, Adam D Howell, Catherine F Moore, Tina L Ta, Marius C Hoener, Valentina Sabino and Pietro Cottone

Neuropsychopharmacology 2017 42: 1458-1470; advance online publication, October 6, 2016; 10.1038/npp.2016.233

Abstract | Full Text

Endogenous Glucagon-like Peptide-1 Receptor Signaling in the Nucleus Tractus Solitarius is Required for Food Intake Control

Amber L Alhadeff, Blake D Mergler, Derek J Zimmer, Christopher A Turner, David J Reiner, Heath D Schmidt, Harvey J Grill and Matthew R Hayes

Neuropsychopharmacology 2017 42: 1471-1479; advance online publication, October 26, 2016; 10.1038/npp.2016.246

Abstract | Full Text

Obesity-Induced Structural and Neuronal Plasticity in the Lateral Orbitofrontal Cortex

Jennifer L Thompson, Michael Drysdale, Corey Baimel, Manpreet Kaur, Taigan MacGowan, Kimberley A Pitman and Stephanie L Borgland

Neuropsychopharmacology 2017 42: 1480-1490; advance online publication, January 2, 2017; 10.1038/npp.2016.284

Abstract | Full Text

Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain

Alessandro Rimessi, Chiara Pavan, Elli Ioannidi, Federica Nigro, Claudia Morganti, Alberto Brugnoli, Francesco Longo, Chiara Gardin, Letizia Ferroni, Michele Morari, Vincenzo Vindigni, Barbara Zavan and Paolo Pinton

Neuropsychopharmacology 2017 42: 1491-1501; advance online publication, January 27, 2017; 10.1038/npp.2017.20

Abstract | Full Text

The Role of The RNA Demethylase FTO (Fat Mass and Obesity-Associated) and mRNA Methylation in Hippocampal Memory Formation

Brandon J Walters, Valentina Mercaldo, Colleen J Gillon, Matthew Yip, Rachael L Neve, Frederick M Boyce, Paul W Frankland and Sheena A Josselyn

Neuropsychopharmacology 2017 42: 1502-1510; advance online publication, February 16, 2017; 10.1038/npp.2017.31

Abstract | Full Text

Activation of Ventral Tegmental Area 5-HT2C Receptors Reduces Incentive Motivation OPEN

Lourdes Valencia-Torres, Cristian M Olarte-Sánchez, David J Lyons, Teodora Georgescu, Megan Greenwald-Yarnell, Martin G Myers, Jr, Christopher M Bradshaw and Lora K Heisler

Neuropsychopharmacology 2017 42: 1511-1521; advance online publication, November 24, 2016; 10.1038/npp.2016.264

Abstract | Full Text

Behavioral Determinants of Cannabinoid Self-Administration in Old World Monkeys

William S John, Thomas J Martin and Michael A Nader

Neuropsychopharmacology 2017 42: 1522-1530; advance online publication, January 6, 2017; 10.1038/npp.2017.2

Abstract | Full Text

Effects of a Serotonin 2C Agonist and a 2A Antagonist on Actigraphy-Based Sleep Parameters Disrupted by Methamphetamine Self-Administration in Rhesus Monkeys

Maylen Perez Diaz, Monica L Andersen, Kenner C Rice and Leonard L Howell

Neuropsychopharmacology 2017 42: 1531-1538; advance online publication, December 16, 2016; 10.1038/npp.2016.280

Abstract | Full Text

Amphetamine and Methamphetamine Increase NMDAR-GluN2B Synaptic Currents in Midbrain Dopamine Neurons

Ming-Hua Li, Suzanne M Underhill, Cheryl Reed, Tamara J Phillips, Susan G Amara and Susan L Ingram

Neuropsychopharmacology 2017 42: 1539-1547; advance online publication, December 15, 2016; 10.1038/npp.2016.278

Abstract | Full Text

RGS9-2 Modulates Responses to Oxycodone in Pain-Free and Chronic Pain States

Sevasti Gaspari, Valeria Cogliani, Lefteris Manouras, Ethan M Anderson, Vasiliki Mitsi, Kleopatra Avrampou, Fiona B Carr and Venetia Zachariou

Neuropsychopharmacology 2017 42: 1548-1556; advance online publication, January 11, 2017; 10.1038/npp.2017.4

Abstract | Full Text

In Memoriam


Thomas Hanlon

William T Carpenter

Neuropsychopharmacology 2017 42: 1557; 10.1038/npp.2017.3

Full Text



Memories of Opiate Withdrawal Emotional States Correlate with Specific Gamma Oscillations in the Nucleus Accumbens

Cyril Dejean, Mathieu Sitko, Paul Girardeau, Amine Bennabi, Stéphanie Caillé, Martine Cador, Thomas Boraud and Catherine Le Moine

Neuropsychopharmacology 2017 42: 1558; 10.1038/npp.2017.46

Full Text

Acute D3 Antagonist GSK598809 Selectively Enhances Neural Response During Monetary Reward Anticipation in Drug and Alcohol Dependence

Anna Murphy, Liam J Nestor, John McGonigle, Louise Paterson, Venkataramana Boyapati, Karen D Ersche, Remy Flechais, Shankar Kuchibatla, Antonio Metastasio, Csaba Orban, Filippo Passetti, Laurence Reed, Dana Smith, John Suckling, Eleanor Taylor, Trevor WR Obbins, Anne Lingford-Hughes, David J Nutt, John FW Deakin, Rebecca Elliott and ICCAM Platform

Neuropsychopharmacology 2017 42: 1559; 10.1038/npp.2017.47

Full Text

Please note that you need to be a subscriber or site-license holder to enjoy full-text access to Neuropsychopharmacology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: